Menu Search
Equities

Intelligent Bio Solutions Inc

12Q0:BER

Intelligent Bio Solutions Inc

Actions
  • Price (EUR)0.00
  • Today's Change0.00 / --
  • Shares traded--
  • 1 Year change-100.00%
  • Beta--
Data delayed at least 15 minutes, as of Jan 29 2024 07:25 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Intelligent Bio Solutions Inc grew revenues 147.58% from 1.26m to 3.11m while net income improved from a loss of 10.63m to a smaller loss of 10.16m.
Gross margin45.81%
Net profit margin-327.50%
Operating margin-330.46%
Return on assets-84.45%
Return on equity-167.49%
Return on investment-156.10%
More ▼

Cash flow in USDView more

In 2024, Intelligent Bio Solutions Inc increased its cash reserves by 310.09%, or 4.77m. Cash Flow from Financing totalled 14.56m or 467.92% of revenues. In addition the company used 9.57m for operations while cash used for investing totalled 221.43k.
Cash flow per share-6.67
Price/Cash flow per share--
Book value per share2.41
Tangible book value per share1.15
More ▼

Balance sheet in USDView more

Intelligent Bio Solutions Inc appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 0.79% of the market capitalization can be attributed to its 6.30m and debt could be paid in full if management chose.
Current ratio1.57
Quick ratio1.42
Total debt/total equity0.0619
Total debt/total capital0.0592
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.